SLC39A9 and cancer: Additional candidates include GPRC6A, a Ca2+ activated G-protein coupled receptor proposed to be identical to mAR [53, 54] or the zinc transporter ZIP9 also proposed to fulfill the role of mAR in cancer cells [55].